Dewei Li
Impact in
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver physiology and pathology
- Liver Disease and Transplantation
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Surgery 18
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
-
- Circular RNAs in diseases 5
- RNA modifications and cancer 4
- Co-authors
- Chengyou Du (8 shared papers)Wei Wang (7 shared papers)Guiling Li (4 shared papers)Kai‐Fu Tang (4 shared papers)Jian Gao (3 shared papers)Keyue Ding (5 shared papers)Zhujun Deng (3 shared papers)Rui Liao (5 shared papers)
- Journals
- Frontiers in Oncology (3 papers)Journal of Cellular Physiology (3 papers)World Journal of Surgical Oncology (2 papers)Oncotarget (2 papers)Energy & Fuels (2 papers)
- Partner nations
- ChinaUnited StatesThailand
In The Last Decade
Dewei Li
74 papers receiving 953 citations
Peers
Comparison fields: 5 of 109
- Hepatology 184
- Cancer Research 105
- Epidemiology 172
- Oncology 106
- Pathology and Forensic Medicine 65
Countries citing papers authored by Dewei Li
This map shows the geographic impact of Dewei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dewei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dewei Li more than expected).
Fields of papers citing papers by Dewei Li
This network shows the impact of papers produced by Dewei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dewei Li. The network helps show where Dewei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Dewei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 82 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 129 | |
| 2 | 2013 | 47 | |
| 3 | 2021 | 42 | |
| 4 | 2019 | 41 | |
| 5 | 2019 | 35 | |
| 6 | 2019 | 33 | |
| 7 | 2020 | 32 | |
| 8 | 2015 | 29 | |
| 9 | 2022 | 26 | |
| 10 | 2017 | 26 | |
| 11 | 2018 | 25 | |
| 12 | 2018 | 25 | |
| 13 | 2017 | 24 | |
| 14 | 2018 | 20 | |
| 15 | 2022 | 18 | |
| 16 | 2018 | 18 | |
| 17 | 2024 | 18 | |
| 18 | 2016 | 18 | |
| 19 | 2023 | 17 | |
| 20 | 2018 | 17 |
About Dewei Li
Dewei Li is a scholar working on Surgery, Molecular Biology, Hepatology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 82 papers that have together received 970 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers), Liver physiology and pathology (7 papers), Circular RNAs in diseases (5 papers), MicroRNA in disease regulation (5 papers), Cancer-related molecular mechanisms research (4 papers), Fuel Cells and Related Materials (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Hepatology (184 citations), Cancer Research (105 citations), Epidemiology (172 citations), Oncology (106 citations) and Pathology and Forensic Medicine (65 citations). Dewei Li has collaborated with scholars based in China, United States and Thailand. Frequent co-authors include Chengyou Du, Wei Wang, Guiling Li, Kai‐Fu Tang, Jian Gao, Keyue Ding, Zhujun Deng, Rui Liao, YiJiang Song and Junzhou Tang. Their work appears in journals such as Frontiers in Oncology, Journal of Cellular Physiology, World Journal of Surgical Oncology, Oncotarget and Energy & Fuels.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.